NCT02820961 2021-12-15Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast CancerSyndax PharmaceuticalsPhase 1 Completed61 enrolled
NCT04088110 2019-09-12Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast CancerFuzhou General HospitalPhase 2 Unknown77 enrolled